Skip to main content
37°
Clear
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
News
Local News
State News
Sports
Local Sports
Pro Sports
Lifestyle
Local Entertainment
Multimedia
Community Choice
Features
Special Sections
Local Events
Weather
Classifieds
Place Ad
Legal Notices
Place Call Legal
Search Call Legals
Place Times Legal
Search Times Legals
Public Notices
Obituaries
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Eton Pharmaceuticals, Inc. - Common Stock
(NQ:
ETON
)
12.76
-0.22 (-1.69%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 1, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Eton Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
5 Analysts Assess Eton Pharmaceuticals: What You Need To Know
March 19, 2025
Via
Benzinga
Earnings Scheduled For March 18, 2025
March 18, 2025
Via
Benzinga
Eton Pharma Plans FDA Filing For ET-600 Oral Desmopressin Next Month, Eyes 2026 Launch
March 14, 2025
Eton Pharmaceuticals' ET-600 met bioequivalence standards in a study, with an FDA filing planned for April 2025 and a potential launch in early 2026.
Via
Benzinga
Exposures
Product Safety
12 Health Care Stocks Moving In Friday's Pre-Market Session
March 14, 2025
Via
Benzinga
The Analyst Verdict: Eton Pharmaceuticals In The Eyes Of 5 Experts
January 08, 2025
Via
Benzinga
Analyst Expectations For Eton Pharmaceuticals's Future
November 13, 2024
Via
Benzinga
Rocket Companies, Novo Nordisk And Other Big Stocks Moving Lower In Monday's Pre-Market Session
March 10, 2025
Via
Benzinga
Earnings Scheduled For November 12, 2024
November 12, 2024
Via
Benzinga
Earnings Outlook For Eton Pharmaceuticals
November 11, 2024
Via
Benzinga
Critical Insights From Eton Pharmaceuticals Analyst Ratings: What You Need To Know
October 28, 2024
Via
Benzinga
3 Stocks Insiders Are Buying Heavily In October 2024, And Why
October 09, 2024
Should investors add these stocks on their watchlist? Insider buys suggest so.
Via
Talk Markets
Domino's Pizza To Rally Over 38%? Here Are 10 Top Analyst Forecasts For Friday
October 04, 2024
Via
Benzinga
Recap: Eton Pharmaceuticals Q4 Earnings
March 14, 2024
Via
Benzinga
Eton Pharmaceuticals Earnings Preview
March 13, 2024
Via
Benzinga
Is NASDAQ:ETON suited for growth investing?
March 06, 2024
ETON PHARMACEUTICALS INC (NASDAQ:ETON) may be suited for growth investing, we'll explore why in this article.
Via
Chartmill
Why the growth investor may take a look at NASDAQ:ETON.
February 14, 2024
Exploring ETON PHARMACEUTICALS INC (NASDAQ:ETON)'s growth characteristics.
Via
Chartmill
ETON Stock Earnings: Eton Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024
August 08, 2024
ETON stock results show that Eton Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via
InvestorPlace
ETON Stock Earnings: Eton Pharmaceuticals Beats EPS, Misses Revenue for Q1 2024
May 09, 2024
ETON stock results show that Eton Pharmaceuticals beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
March 22, 2024
Via
Benzinga
ETON Stock Earnings: Eton Pharmaceuticals Misses EPS, Misses Revenue for Q4 2023
March 14, 2024
ETON stock results show that Eton Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Gilead Sciences Tops Q3 Earnings And Revenue Estimates
November 07, 2023
While Gilead has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
Via
Talk Markets
Earnings Scheduled For March 14, 2024
March 14, 2024
Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter.
Via
Benzinga
Evaluating NASDAQ:ETON for Growth Investment Opportunities.
January 22, 2024
Exploring ETON PHARMACEUTICALS INC (NASDAQ:ETON)'s growth characteristics.
Via
Chartmill
Eton Pharmaceuticals: Q3 Earnings Insights
November 09, 2023
Via
Benzinga
Why Maxeon Solar Technologies Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Friday's Mid-Day Session
August 11, 2023
Gainers Amyris, Inc. (NASDAQ: AMRS) shares jumped 179.1% to $0.1839. Amyris shares dipped over 80% on Thursday after the company announced it filed for Chapter 11 bankruptcy.
Via
Benzinga
Topics
Bankruptcy
Exposures
Financial
Legal
12 Health Care Stocks Moving In Friday's Intraday Session
August 11, 2023
Via
Benzinga
Consolidated Water, Spectrum Brands, Arco Platform, Semler Scientific And Other Big Stocks Moving Higher On Friday
August 11, 2023
U.S. stocks traded mixed, with the Dow Jones gaining around 80 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
FSR Stock Alert: What to Know About the New Fisker Ronin EV
August 11, 2023
Fisker (FSR) stock is in the news Friday after the company provided customers with more details about the upcoming Fisker Ronin Super GT EV.
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
August 11, 2023
Via
Benzinga
Why Is Cano Health (CANO) Stock Down 48% Today?
August 11, 2023
Cano Health (CANO) stock is taking a beating on Friday after the healthcare company provided a business update in its latest earnings report.
Via
InvestorPlace
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.